缩写名/全名 |
J MED CHEM
JOURNAL OF MEDICINAL CHEMISTRY |
||||||||||||||||||||
ISSN号 | 0022-2623 | ||||||||||||||||||||
研究方向 | 医学-医药化学 | ||||||||||||||||||||
影响因子 | 2015:5.589, 2016:6.259, 2017:6.253, 2018:6.054, 2019:6.205, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Semimonthly | ||||||||||||||||||||
年文章数 | 689 | ||||||||||||||||||||
出版年份 | 1963 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2.1个月 |
||||||||||||||||||||
录用比例 | 较难 | ||||||||||||||||||||
投稿链接 | https://acs.manuscriptcentral.com/acs | ||||||||||||||||||||
投稿官网 | http://pubs.acs.org/journal/jmcmar | ||||||||||||||||||||
h-index | 240 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-2623%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Synthesis and Anti-HCV Activities of 4'-Fluoro-2'-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4'-Fluoro-2'- C-methyluridine 5'-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. Author: Wang G1, Dyatkina N1, Prhavc M1, Williams C1, Serebryany V1, Hu Y2, Huang Y2, Wan J2, Wu X2, Deval J1, Fung A1, Jin Z1, Tan H1, Shaw K1, Kang H1, Zhang Q1, Tam Y1, Stoycheva A1, Jekle A1, Smith DB1, Beigelman L1. Journal: J Med Chem. 2019 May 9;62(9):4555-4570. doi: 10.1021/acs.jmedchem.9b00143. Epub 2019 Apr 19. PubMed DOI |
2. | Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens. Author: Yang Z1, He S1, Wang J1, Yang Y1, Zhang L1, Li Y2, Shan A1. Journal: J Med Chem. 2019 May 9;62(9):4586-4605. doi: 10.1021/acs.jmedchem.9b00149. Epub 2019 Apr 19. PubMed DOI |
3. | Targeting the Thioredoxin System as a Strategy for Cancer Therapy. Author: Bian M1, Fan R1, Zhao S1,2, Liu W1,3. Journal: J Med Chem. 2019 Apr 16. doi: 10.1021/acs.jmedchem.8b01595. [Epub ahead of print] PubMed DOI |
4. | Discovery of [1,2,4]Triazolo[4,3- a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Author: Qin M1, Cao Q1, Zheng S1, Tian Y1, Zhang H2, Xie J2, Xie H3, Liu Y1, Zhao Y1, Gong P1. Journal: J Med Chem. 2019 May 9;62(9):4703-4715. doi: 10.1021/acs.jmedchem.9b00312. Epub 2019 Apr 19. PubMed DOI |
5. | Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. Author: Zhang Y1,2,3, Wu X1,2,3, Xue X1,4, Li C1, Wang J5, Wang R1, Zhang C1,6, Wang C1,2,3, Shi Y1,2,3, Zou L1,2,3, Li Q1,2,3, Huang Z, Hao X7, Loomes K8, Wu D9, Chen HW, Xu J9, Xu Y1,3. Journal: J Med Chem. 2019 May 9;62(9):4716-4730. doi: 10.1021/acs.jmedchem.9b00327. Epub 2019 Apr 22. PubMed DOI |
6. | Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury. Author: Liu Z1, Chen L2, Yu P1,3, Zhang Y1, Fang B1, Wu C1, Luo W1, Chen X1, Li C1, Liang G1,2. Journal: J Med Chem. 2019 Apr 29. doi: 10.1021/acs.jmedchem.9b00316. [Epub ahead of print] PubMed DOI |
7. | Discovery of Pyrrolo[3,2- d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain. Author: Huang L1, Li H1, Li L2, Niu L1, Seupel R3,4, Wu C1, Cheng W1, Chen C1, Ding B1, Brennan PE3,4, Yang S1. Journal: J Med Chem. 2019 May 9;62(9):4526-4542. doi: 10.1021/acs.jmedchem.9b00096. Epub 2019 Apr 30. PubMed DOI |
8. | Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase. Author: Crespo RA1, Dang Q2, Zhou NE1, Guthrie LM3, Snavely TC1, Dong W1, Loesch KA1, Suzuki T4, You L4, Wang W4, O'Malley T5, Parish T5, Olsen DB2, Sacchettini JC1. Journal: J Med Chem. 2019 May 9;62(9):4483-4499. doi: 10.1021/acs.jmedchem.9b00020. Epub 2019 Apr 19. PubMed DOI |
9. | Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. Author: Zhang R1, Song XQ1, Liu RP1, Ma ZY1, Xu JY1. Journal: J Med Chem. 2019 May 9;62(9):4543-4554. doi: 10.1021/acs.jmedchem.9b00128. Epub 2019 Apr 30. PubMed DOI |
10. | Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension. Author: Wang Z1, Jiang X1, Zhang X1,2, Tian G3, Yang R3, Wu J3, Zou X3, Liu Z4, Yang X4, Wu C4, Shi J4, Li J1, Suo J1, Wang Y1, Zhang R1, Xu Z1, Gong X1,5, He Y1, Zhu W1,2, Aisa HA5, Jiang H1,2, Xu Y1,2, Shen J1,2. Journal: J Med Chem. 2019 May 23;62(10):4979-4990. doi: 10.1021/acs.jmedchem.9b00123. Epub 2019 May 8. PubMed DOI |
|
|